We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.81B
AUM Growth
–
Cap. Flow
+$4.76B
Cap. Flow %
98.8%
Top 10 Hldgs %
46.28%
Holding
74
New
72
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$362M
2
PFE icon
Pfizer
PFE
+$309M
3
ETN icon
Eaton
ETN
+$287M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$243M
5
TMO icon
Thermo Fisher Scientific
TMO
+$210M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 37.44%
2 Communication Services 15.27%
3 Industrials 11.82%
4 Consumer Discretionary 7.56%
5 Real Estate 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
51
Cigna
CI
$77.3B
$17.3M 0.36%
+238,893
New +$16.1M
TSRO
52
DELISTED
TESARO, Inc.
TSRO
$16.4M 0.34%
+502,438
New +$15.5M
CME icon
53
CME Group
CME
$92.6B
$16.1M 0.33%
+212,175
New +$13.9M
ALGN icon
54
Align Technology
ALGN
$12.1B
$14.1M 0.29%
+380,020
New +$13.1M
REGN icon
55
Regeneron Pharmaceuticals
REGN
$70.5B
$12.3M 0.25%
+54,565
New +$12.7M
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$12.1M 0.25%
+196,696
New +$11.8M
CFN
57
DELISTED
CAREFUSION CORPORATION
CFN
$11.8M 0.25%
+321,012
New +$11.3M
MOH icon
58
Molina Healthcare
MOH
$10.6B
$11.6M 0.24%
+312,503
New +$11M
EPZM
59
DELISTED
Epizyme, Inc
EPZM
$11.5M 0.24%
+408,608
New +$10.5M
COO icon
60
Cooper Companies
COO
$13.8B
$11.3M 0.23%
+378,756
New +$10.6M
EXAS
61
DELISTED
Exact Sciences
EXAS
$6.68M 0.14%
+480,401
New +$5.22M
GNMK
62
DELISTED
GenMark Diagnostics, Inc
GNMK
$6.25M 0.13%
+604,199
New +$8.33M
IDIX
63
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$4.21M 0.09%
+1,166,298
New +$4.77M
WAT icon
64
Waters Corp
WAT
$36.5B
$4.19M 0.09%
+41,855
New +$4.01M
BB icon
65
BlackBerry
BB
$4.91B
$4.11M 0.09%
+392,958
New +$5.69M
GWPH
66
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.41M 0.07%
+386,844
New +$3.43M
RAD
67
DELISTED
Rite Aid Corporation
RAD
$2.92M 0.06%
+51,040
New +$2.66M
MRK icon
68
Merck
MRK
$324B
$2.1M 0.04%
+47,434
New +$2.12M
MRK icon
69
CALL
Merck
MRK
$324B
$506K 0.01%
+631,001
New +$28.2M
HCA icon
70
CALL
HCA Healthcare
HCA
$86.4B
$345K 0.01%
+431,200
New +$16.7M
ISRG icon
71
PUT
Intuitive Surgical
ISRG
$128B
$136K ﹤0.01%
+92,700
New +$5.11M
VOLC
72
CALL
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$99K ﹤0.01%
+96,700
New +$1.85M
1 2
3

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for PFM Health Sciences, which disclosed 74 positions worth $4.81B. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Gilead Sciences: 6,954,488 shares worth $357M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Communication Services and Industrials.

  • PFM Health Sciences's largest Q2 2013 buy was Gilead Sciences: 6,954,488 shares worth $357M.
  • PFM Health Sciences's ten largest holdings make up 46% of its $4.81B portfolio in Q2 2013.
  • PFM Health Sciences disclosed 74 positions in Q2 2013, its first 13F filing on record.

Based on PFM Health Sciences's 13F filing for Q2 2013, filed 14 Aug 2013.